Skip to search boxSkip to navigationSkip to main content

The polyaromatic hydrocarbon β-naphthoflavone alters binding of YY1, Sp1, and Sp3 transcription factors to the Dp71 promoter in hepatic cells

  • Carolina Becerril-Esquivelb, c(Author)
    ,
  • Katia Peñuelas-Urquidesb(Author)
    ,
  • Erik Blancas-Sánchezb, c(Author)
    ,
  • Pablo Zapata-Benavidesc(Author)
    ,
  • Beatriz Silva-Ramírezb(Author)
    ,
  • Arturo Chávez-Reyesd(Author)
  • aInstituto Tecnologico de Estudios Superiores de Monterrey
    ,
  • bInstituto Mexicano del Seguro Social
    ,
  • cUniversidad Autonoma de Nuevo Leon
    ,
  • dCentro de Investigacion y de Estudios Avanzados del Instituto Politécnico Nacional
    ,
  • eDepartamento de Biología Molecular
Research Output: Contribution to journal Article Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication metrics

Metrics

SciVal
FWCI
0.07
Scopus
Citations

PlumX, opens in new tab

Captures
10
Citations
1

Abstract

© 2018 Kashyap. The smallest product of the Duchenne muscular dystrophy gene, dystrophin (Dp)71, is ubiquitously expressed in nonmuscle tissues. We previously showed that Dp71 expression in hepatic cells is modulated in part by stimulating factor 1 (Sp1), stimulating protein 3 (Sp3), and yin yang 1 (YY1) transcription factors, and that the polyaromatic hydrocarbon, β-naphthoflavone (β-NF), downregulates Dp71 expression. The aim of the present study was to determine whether β-NF represses Dp71 expression by altering mRNA stability or its promoter activity. Reverse transcription-quantitative polymerase chain reaction was used to measure half-life mRNA levels in β -NF-treated cells exposed to actinomycin D, an inhibitor of transcription, for 0, 4, 8, 12 and 16 h. Transient transfections with a plasmid carrying the Dp71 basal promoter fused to luciferase reporter gene were carried out in control and β -NF-treated cells. Electrophoretic mobility shift assays (EMSAs) were performed with labeled probes, corresponding to Dp71 promoter sequences, and nuclear extracts of control and β -NF-treated cells. To the best of our knowledge, the results demonstrated for the first time that this negative regulation takes place at the promoter level rather than the mRNA stability level. Interestingly, using EMSAs, β-NF reduced binding of YY1, Sp1, and Sp3 to the Dp71 promoter. It also suggests that β-NF may modulate the expression of other genes regulated by these transcription factors. In conclusion, β-NF represses Dp71 expression in hepatic cells by altering binding of YY1, Sp1, and Sp3 to the Dp71 promoter.

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 6150-6155 (6 pages)

Journal (Volume, Issue Number)

Molecular Medicine Reports (Volume 17, Issue 4)

Publication milestones

  • Published
    - 01/04/2018

Publication status

Published
- 01/04/2018

ISSN

1791-2997

External Publication IDs

  • Scopus: 85043242235
  • PubMed: 29484433
  • Scopus: 85043242235

Funding Details

The present study was supported by Consejo Nacional de Ciencia y Tecnología (CONACyT)-Mexico (grant number 78764-M) for MBL.
FundersFunding numbers
CONACYT
78764-M
CONACYT
-